Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33

Conditions:   Advanced Solid Tumors;   Advanced Esophagus Cancer and Squamous Cell Carcinoma of the Esophageal Junction
Intervention:   Drug: CYH33 for tablet
Sponsor:   ShangHai HaiHe Pharmaceutical
Recruiting

https://ift.tt/2MgsO4F